139 results
8-K
EX-99.1
BPTH
Bio-Path Holdings Inc
8 Mar 24
Bio-path Holdings Reports Full Year 2023 Financial Results
7:10am
, for the year ended December 31, 2022.
Research and development expense for the year ended December 31, 2023 increased to $11.6 million, compared to $9.2
8-K
EX-99.1
BPTH
Bio-Path Holdings Inc
15 Nov 23
Bio-path Holdings Reports Third Quarter 2023 Financial Results
7:30am
.
Research and development expense for the three months ended September 30, 2023 decreased to $2.3 million, compared to $2.4 million for the three
8-K
EX-99.1
BPTH
Bio-Path Holdings Inc
15 Aug 23
Bio-path Holdings Reports Second Quarter 2023 Financial Results
7:10am
.
Research and development expense for the three months ended June 30, 2023 increased to $3.1 million, compared to $1.9 million for the three months ended
8-K
EX-99.1
sec 0td1l7
12 May 23
Bio-path Holdings Reports First Quarter 2023 Financial Results
7:10am
8-K
EX-99.1
b3tx6mzo9yzy593uc
31 Mar 23
Bio-path Holdings Reports Full Year 2022 Financial Results
7:10am
8-K
EX-99.1
aluhoydt
15 Nov 22
Bio-path Holdings Reports Third Quarter 2022 Financial Results
7:30am
8-K
EX-99.1
6ipeszs2
16 Aug 22
Bio-path Holdings Reports Second Quarter 2022 Financial Results
7:30am
424B5
o6u2hi 1207g
29 Jul 22
Prospectus supplement for primary offering
5:09pm
424B5
eps5 7nzan6e
14 Jun 22
Prospectus supplement for primary offering
5:19pm
424B5
siuwf9i87 hbez
14 Jun 22
Prospectus supplement for primary offering
5:18pm
8-K
EX-99.1
jhnw20 sn3n
17 May 22
Bio-path Holdings Reports First Quarter 2022 Financial Results
7:30am